2023
Missorting of plasma miRNAs in aging and Alzheimer's disease
CARNA, Maria; Jan S. NOVOTNY; Neda DRAGISIC; Hanus SLAVIK; Kateřina SHEARDOVÁ et. al.Basic information
Original name
Missorting of plasma miRNAs in aging and Alzheimer's disease
Authors
CARNA, Maria; Jan S. NOVOTNY; Neda DRAGISIC; Hanus SLAVIK; Kateřina SHEARDOVÁ; Yonas E. GEDA; Martin VYHNALEK; Jan LACZO; Jakub HORT; Zixu MAO; Robert A. RISSMAN; Marian HAJDUCH; Eric B. DAMMER and Gorazd B. STOKIN
Edition
Journal of Neurochemistry, Hoboken, Wiley-Blackwell, 2023, 0022-3042
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
30210 Clinical neurology
Country of publisher
United States of America
Confidentiality degree
is not subject to a state or trade secret
References:
Impact factor
Impact factor: 4.200
RIV identification code
RIV/00216224:14110/23:00130750
Organization unit
Faculty of Medicine
UT WoS
000959282900001
EID Scopus
2-s2.0-85151484652
Keywords in English
aging; Alzheimer's disease; endosomes; extracellular vesicles; miRNA; ncRNA; plasma; short sequence motifs
Tags
International impact, Reviewed
Changed: 10/5/2023 14:06, Mgr. Tereza Miškechová
Abstract
In the original language
The observation that aging is regulated by microRNAs (miRNA) and at the same time represents the greatest risk factor for Alzheimer's disease (AD), prompted us to examine the circulating miRNA network in AD beyond aging. We here show that plasma miRNAs in aging are downregulated and predicted to be preferentially targeted to the extracellular vesicle (EV) content. In AD, miRNAs are further downregulated, display altered proportions of motifs relevant to their loading into EVs and secretion propensity, and are forecast to be found exclusively in EVs. The circulating miRNA network in AD, therefore, reflects pathological exacerbation of the aging process whereby physiological suppression of AD pathology by miRNAs becomes insufficient.